TY - JOUR
KW - opioid use disorder
KW - Medication for opioid use disorders
KW - system of care
KW - Hub and spoke
KW - Empirical Study
KW - Quantitative Study
KW - Human
KW - Male
KW - Female
KW - Adulthood (18 yrs & older)
KW - Thirties (30-39 yrs)
KW - Middle Age (40-64 yrs)
KW - Drug Overdoses
KW - methadone maintenance
KW - buprenorphine
KW - Drug Therapy
KW - Substance use disorder
KW - Opiates
KW - Mental Health
KW - Death and Dying
KW - Substance use treatment
KW - article
KW - US
KW - 3383:Drug & Alcohol Rehabilitation
AU - Richard Rawson
AU - Sarah J. Cousins
AU - Michael McCann
AU - Regina Pearce
AU - Anne Van Donsel
A1 - 
AD - Vermont Center for Behavior and Health, Lerner School of Medicine, University of Vermont, Burlington, VT, US rrawson@uvm.edu; Integrated Substance Abuse Programs, Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, US ; Alcohol and Drug Abuse Programs, Department of Health, State of Vermont, Burlington, VT, US ; Rawson, Richard,1952 Rte 73,Brandon,US,05733,Center for Behavior and Health, Department of Psychiatry, University of Vermont,rrawson@uvm.edu
BT - Journal of substance abuse treatment
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
DO - 10.1016/j.jsat.2018.11.003
JF - Journal of substance abuse treatment
LA - English
M1 - Journal Article
PB - Elsevier Science
PY - 2019
SN - 0740-5472, 0740-5472
SP - 84
EP - 90
EP - 
T1 - Assessment of medication for opioid use disorder as delivered within the Vermont hub and spoke system
T2 - Journal of substance abuse treatment
TI - Assessment of medication for opioid use disorder as delivered within the Vermont hub and spoke system
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U3 - 10.1016/j.jsat.2018.11.003
UR - https://www.proquest.com/scholarly-journals/assessment-medication-opioid-use-disorder-as/docview/2406657521/se-2?accountid=28100
VL - 97
VO - 0740-5472, 0740-5472
Y1 - 2019
Y2 - 02
ER -